10(E)-Pentadecenoic Acid Inhibits Melanogenesis Partly Through Suppressing the Intracellular MITF/Tyrosinase Axis
- Antioxidants (Basel). 2024 Dec 17;13(12):1547. doi: 10.3390/antiox13121547.
- 1. Department of Food Science and Nutrition, Pukyong National University, Busan 48513, Republic of Korea.
- 2. Biotechnology Research Division, National Institute of Fisheries Science, Busan 46083, Republic of Korea.
- 3. Department of Smart Green Technology Engineering, Pukyong National University, Busan 48513, Republic of Korea.
- 4. Marine Integrated Biomedical Technology Center, The National Key Research Institutes, Pukyong National University, Busan 48513, Republic of Korea.
Melanogenesis, the biological process responsible for melanin synthesis, plays a crucial role in determining skin and hair color, photoprotection, and serving as a biomarker in various diseases. While various factors regulate melanogenesis, the role of fatty acids in this process remains underexplored. This study investigated the anti-melanogenic properties of 10(E)-pentadecenoic acid (10E-PDA) through both in silico and in vitro analyses. SwissSimilarity was utilized to predict the functional properties of 10E-PDA by comparing it with structurally similar lipids known to exhibit anti-melanogenic effects. Subsequent in vitro experiments demonstrated that 10E-PDA significantly reduced melanin production and intracellular Tyrosinase activity in α-MSH (melanocyte-stimulating hormone)-stimulated B16F10 melanoma cells without exhibiting significant cytotoxicity at concentrations up to 15 μM. Further mechanistic studies revealed that 10E-PDA inhibited the nuclear translocation of microphthalmia-associated transcription factor (MITF), consistent with the decrease observed in p-MITF protein levels. It also decreased the mRNA levels of tyrosinase-related proteins (TRP-1, TRP-2) and Tyrosinase, while reducing the protein levels of TRP-1 and Tyrosinase, but not TRP-2. These findings suggest that 10E-PDA exerts its anti-melanogenic effects by modulating the MITF/Tyrosinase axis, presenting potential therapeutic implications for skin pigmentation disorders.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Metabolic Disease